Clinical Research Details

Clinical Research

GS-US-417-0303: A Randomized, Double-blind, Placebo-and Active-controlled, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Filgotinib Administered for 52 Weeks Alone and in Combination with Methotrexate (MTX) to Subjects with Moderately to Severly Active Rheumatoid Arthritis Who Are Naïve to MTX Therapy

Study Description

The purpose of this study is to see if filgotinib can be useful to treat RA as single therapy or in combination with Methotrexate (MTX).

Investigators


Principal Investigator
Gurjit S. Kaeley, M.D.
Medicine

Sub Investigator
Karishma Ramsubeik, M.B.B.S. (M.D.)
Medicine

Sub Investigator
Myint Thway, M.D.
Medicine